Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma
- 1 June 1994
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 170 (6) , 1677-1682
- https://doi.org/10.1016/s0002-9378(94)70340-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Evaluation of unfavorable histologic subtypes in endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1990
- Features associated with survival and disease-free survival in early endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1989
- Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometriumGynecologic Oncology, 1987
- Stage II carcinoma of the endometrium: Results of therapy and prognostic factorsInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinomaCancer, 1982
- Uterine papillary serous carcinomaThe American Journal of Surgical Pathology, 1982
- Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy☆Gynecologic Oncology, 1980
- Stage II carcinoma of the endometriumInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Doxorubicin-cyclophosphamide: Effective chemotherapy for advanced endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1977
- Postoperative external pelvic irradiation in carcinoma of the corpus stage I: A controlled clinical trialGynecologic Oncology, 1976